Dyne Therapeutics, Inc. (DYN) Insider Trading

Name: Dyne Therapeutics, Inc. (DYN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 6, 2026): Brian S. Posner (Director): Purchase of 2,500 shares, $40.0K.

Get alerted when insiders trade DYN

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta